Skip to main content
. Author manuscript; available in PMC: 2008 Nov 1.
Published in final edited form as: Clin Neurophysiol. 2007 Sep 25;118(11):2413–2418. doi: 10.1016/j.clinph.2007.08.004

Figure 3.

Figure 3

Plot of potential power for three different effect sizes for each of the measures investigated based on the 1-year study design described in the text. Note that the ALSFRS-R and MVICT megascore values virtually overlie one another. *Data derived from celecoxib in ALS study (Cudkowicz et al, 2006).